Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely.

Ayelet GrupperHelena Katchman

Published in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2021)

Keyphrases

sars cov
immune response
respiratory syndrome coronavirus
binding protein